Each year, over 15,000 children in the US are diagnosed with cancer — 1,600 will lose their lives. We are closer than ever to changing this, but progress isn't guaranteed. Pediatric cancer is critically underfunded, and existing models don't always reach the areas of greatest need. The barriers that slow progress most — siloed research, infrastructure gaps, drug access, ineffective policy — are largely invisible to those outside the clinic.
That's where Golden Thread comes in.
Advancement in medicine is not linear. Without intentional coordination, communication gaps and fragmented efforts create additional barriers that slow discovery.
Progress in pediatric cancer requires strategic alignment across research, advocacy, philanthropy, and industry.

Ashley Margol, MD, MS
Ashley Margol
MD, MS
Co-Founder

Cassie Kline, MD, MAS
Cassie Kline
MD, MAS
Co-Founder

Jeremy Bender, PhD, MBA
Jeremy Bender
PhD, MBA

Scott Conrad
Scott Conrad

Kelli Martin, JD
Kelli Martin
JD

Rachel Murray, MS, MBA
Rachel Murray
MS, MBA

Annabelle Ostin, JD
Annabelle Ostin
JD

SoYoung Park, MBA
SoYoung Park
MBA
Ashley Margol, MD, MS
Ashley is a pediatric neuro-oncologist, Director of the Brain Tumor Center and Neuro-Oncology Program at Children's Hospital Los Angeles (CHLA), and Associate Professor of Clinical Pediatrics at the Keck School of Medicine of University of Southern California (USC). Dr. Margol specializes in treating young children with brain tumors and has been actively involved in pediatric cancer advocacy. Dr. Margol serves as co-leader of the Pediatric Neuro-Oncology Consortium (PNOC) and leads or co-leads multiple clinical trials for children with brain tumors, with a focus on developing novel therapeutic approaches and trial designs for rare diseases.
Dr. Margol earned her B.S. from the University of Florida and her M.D. and M.S. in Clinical, Biomedical and Translational Research from the Keck School of Medicine of USC. She completed her residency training in pediatrics and served as chief resident at Los Angeles County/USC Medical Center before moving to CHLA for pediatric hematology-oncology and neuro-oncology fellowship.
With over a decade of experience caring for children with cancer, Dr. Margol recognized the need to address systemic barriers that slow progress in pediatric oncology. She co-founded Golden Thread with Dr. Cassie Kline, to create integrated solutions that accelerate meaningful advances in pediatric cancer research, treatment and outcomes.

Cassie Kline, MD, MAS
Cassie Kline is a pediatric neuro-oncologist and Director of Neuro-Oncology Clinical Research at the Children's Hospital of Philadelphia (CHOP). Dr. Kline specializes in clinical trial innovation, therapeutic development for pediatric CNS tumors, and health equity in pediatric oncology. She is a co-leader of the Pediatric Neuro-Oncology Consortium (PNOC) and leads or co-leads multiple clinical trials investigating novel approaches for children with hard-to-treat brain tumors. Dr. Kline earned her B.S. in biology from the University of Virginia, M.D. from the University of California, San Diego and an M.A.S. in Clinical Research from University of California, San Francisco (UCSF). She completed her residency training in pediatrics at CHOP and pediatric hematology-oncology fellowship at UCSF. She served on the UCSF faculty before returning to CHOP as the inaugural Director of Clinical Research for the Neuro-Oncology section. As the first in her family to graduate from college and medical school, Dr. Kline brings a unique perspective to addressing systemic barriers in pediatric oncology. She co-founded Golden Thread with Dr. Ashley Margol to create integrated, sustainable solutions that advance pediatric cancer research and improve outcomes for children, adolescents, and young adults affected by cancer.

Jeremy Bender, PhD, MBA
Jeremy Bender is the Chief Executive Officer, President and a member of board of directors of Day One Biopharmaceuticals. Prior to joining Day One, Dr. Bender was Vice President of Corporate Development at Gilead Sciences. He previously also held roles as Chief Operating Officer of Tizona Therapeutics and Chief Business Officer of Sutro Biopharma, both of which focused on development of new cancer medicines. Dr. Bender is also an independent member of the Boards of Mereo BioPharma and Vima Therapeutics. He holds a B.S. in Biological Sciences from Stanford University, a Ph.D. in Microbiology and Immunology from the University of Colorado, and an M.B.A. from the MIT Sloan School of Management.

Scott Conrad
Scott Conrad is an accomplished business professional bringing over forty years of experience as an executive, officer, and board member of two of the largest commercial construction and development companies in the United States. Leading multi-billion dollar organizations with thousands of employees and offices throughout the country, Scott brings vast experience in organizational development, change management, corporate governance and financial acumen.
Throughout Scott’s career he has been instrumental in growing organizations by expanding their scope of services, acquiring new companies, and opening new offices and territories. Scott is known for challenging the status quo, stretching preconceived boundaries, and inspiring teams dedicated to process improvement and enhanced efficiency. Scott grew up in the Midwest and graduated from Bowling Green State University with a business degree in Construction Management. Since then, Scott has lived and worked in cities throughout the U.S. and currently resides in the mountains of Colorado with his family. Throughout his extensive career Scott has always dedicated time to community, industry, and nonprofit groups including leadership and board of director positions with the Colorado Symphony, Rocky Mountain Repertory Theater, Associated General Contractors of America, and the Urban land Institute, among others.

Kelli Martin, JD
Kelli Martin is Associate Vice President of Operations at the College Foundation of the University of Virginia, where she oversees key functions including Human Resources, Legal and Compliance, Information Technology, Business Intelligence, Governance, and Finance. Her leadership ensures operational excellence and strategic alignment with the Foundation’s mission. Kelli is a licensed attorney with extensive experience in non-profit risk management, corporate governance, and organizational strategy. She has held roles at EverBank (now part of TIAA) and Bank of America, where she focused on trust review, regulatory analysis, and institutional banking operations. She is a co-founder of Global Oak Capital Markets, a boutique investment bank designed to enhance asset management efficiency through modern infrastructure and technology. In her role as General Counsel and Head of Administration & Human Resources, she led contract negotiations, regulatory engagement, and operational development. She holds a B.A. in Foreign Affairs from the University of Virginia and a J.D. from The George Washington University Law School.

Rachel Murray, MS, MBA
Rachel Murray is a Managing Director at Moelis & Company, where she specializes in Capital Structure Advisory. Rachel has extensive investment banking experience advising corporates, acquirers and creditors across a broad range of industries and geographies.
Prior to joining Moelis & Company, Rachel worked in the financial services practice at Deloitte. She holds an M.B.A. from The Wharton School at the University of Pennsylvania, an Masters in Accounting from the Leventhal School at the University of Southern California and an A.B. in Government from Harvard.

Annabelle Ostin, JD
Annabelle Monet Ostin is a humanitarian attorney dedicated to advocating for immigrant families and protecting children's rights. She served as a Staff Attorney at the Loyola Immigrant Justice Clinic, where she provided legal advocacy to underrepresented immigrant communities with a focus on humanitarian relief for women and children. In this role, she guided clients through complex immigration processes and established the clinic's social work program to provide comprehensive wraparound services. Annabelle earned her B.A. from the University of Southern California, where she studied Communication and Music Industry, and her J.D from Loyola Law School. Prior to her legal career, Annabelle worked in the entertainment industry at Mayflower Entertainment and Creative Artists Agency (CAA). Annabelle has been actively involved with organizations including This Is About Humanity, IMMDEF, and the Loyola Immigrant Justice Clinic, and has served on the board of Foster Nation, all of which are committed to supporting vulnerable communities and advancing human rights. She resides in Santa Monica with her family.

SoYoung Park, MBA
SoYoung Park is strategy & operations lead for Google Search, enabling design quality and effective execution for one of the world’s most fascinating and powerful digital products. Before Google, SoYoung headed product development at cannabis start-up Dosist and was a Senior Director at IDEO, where she led multidisciplinary teams inventing everything from beauty drinks, five star hotels to robotic arms. She holds an A.B. in Psychology and M.B.A. from Harvard.
